Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Browse the world's most comprehensive archive of hedge fund manager letters. Access primary source research from leading institutional managers, sorted by reporting period.
Extreme equity concentration and aggressive AI capital spending have driven market valuations to unsustainable peaks. As hyperscaler cash flows deteriorate and heavy depreciation sets in, technology earnings face substantial downward pressure. Portfolios are actively paring technology exposure in favor of molecular medicine, automation, and non-U.S. equities benefiting from lower valuations and post-conflict stabilization.
Full Quick Take
Extreme equity concentration and aggressive AI capital spending have driven market valuations to unsustainable peaks. As hyperscaler cash flows deteriorate and heavy depreciation sets in, technology earnings face substantial downward pressure. Portfolios are actively paring technology exposure in favor of molecular medicine, automation, and non-U.S. equities benefiting from lower valuations and post-conflict stabilization.
